As stated above, paclitaxel‐elicited EV‐Apo could promote the invasion and chemoresistance of the co‐cultured breast cancer cells, whereas BHS at nontoxic concentrations synergized with paclitaxel to reverse that. Here, AOPEP is linked to breast carcinoma.